Canine Therapeutic Solutions

IMPORTANT SAFETY INFORMATION: VETMEDIN^®-CA1 (pimobendan) It is a violation of Federal law to use VETMEDIN-CA1 other than as directed in the labeling. VETMEDIN-CA1 is conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-556. Adverse reactions not related to disease progression in dogs receiving VETMEDIN-CA1 included diarrhea, vomiting, pain, lameness, arthritis, urinary tract infection, and seizure. For more information, please refer to the package insert.

IMPORTANT SAFETY INFORMATION: VETMEDIN^® (pimobendan) Chewable Tablets and and VETMEDIN(R) Solution (pimobendan oral solution) are for use only in dogs with clinical evidence of heart failure. The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia. VETMEDIN should not be given in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. For more information, please see full prescribing information for Solution or full prescribing information for Chewable Tablets.

IMPORTANT SAFETY INFORMATION: PROZINC^® (protamine zinc recombinant human insulin) is for use in cats and dogs only. The most common insulin-related side effect is hypoglycemia. PROZINC is contraindicated during episodes of hypoglycemia and in animals sensitive to protamine zinc recombinant insulin or any other ingredients in PROZINC. For more information, please see full prescribing information.

IMPORTANT SAFETY INFORMATION: METACAM^® (meloxicam oral suspension) is for use in dogs only. As a class, cyclooxygenase inhibitory NSAIDs may be associated with renal, gastrointestinal, and hepatic toxicity. Dogs with known hypersensitivity to meloxicam should not receive METACAM Oral Suspension. Do not use METACAM Oral Suspension in cats. Repeated use of meloxicam in cats has been associated with acute renal failure and death. For more information, please see full prescribing information.

IMPORTANT SAFETY INFORMATION: METACAM^® (meloxicam) Solution for Injection can be used for dogs and cats. As a class, cyclooxygenase inhibitory NSAIDs may be associated with renal, gastrointestinal, and hepatic toxicity. Animals with known hypersensitivity to meloxicam should not receive METACAM Injection. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. For more information, please see full prescribing information.

IMPORTANT SAFETY INFORMATION: PREVICOX^® (firocoxib) Chewable Tablets are for use in dogs only. As a class, cyclooxygenase inhibitory NSAIDs may be associated with renal, gastrointestinal, and hepatic toxicity. Dogs with known hypersensitivity to firocoxib should not receive PREVICOX. For more information, please see full prescribing information.

IMPORTANT SAFETY INFORMATION: TRESADERM^® (thiabendazole, dexamethasone, neomycin sulfate solution) is for topical use only in cats and dogs. Avoid contact with eyes. Side effects with TRESADERM are relatively rare, but they may include erythema or discomfort at the application site, increased thirst, and gastrointestinal disturbances. For more information, please see full prescribing information.